Table 3.
The usefulness of hepatic fibrosis scoring systems in pediatric patients diagnosed with NAFLD
Hepatic fibrosis score |
Parameters used |
Accuracy in pediatric patients |
AST/ALT ratio |
AST, ALT |
|
APRI |
AST, platelets |
High [9] |
Forns index |
Total bilirubin, GGT, α2-macroglobulin, apolipoprotein A1, haptoglobin. |
Moderate [9] |
FIB-4 score |
Age, AST, ALT, platelets |
High accuracy in differentiating significant from mild fibrosis [9]. |
ELF test |
HA, PIIINP, TIMP-1 |
Good accuracy for differentiating significant fibrosis (stage 3) from mild or no fibrosis (AUROC=0.99, 10.51 cutoff) [4]. |
PNFI |
Age, waist circumference, triglyceride level. |
Good accuracy for differentiating hepatic fibrosis from no fibrosis (AUROC=0.85, 0.76 respectively) [3, 10]. |
PNFI + ELF test |
– |
Excellent accuracy for the prediction of hepatic fibrosis (AUROC=0.94) [3]. |
ALT: Alanine aminotransferase; APRI: AST to platelet ratio index; AST: Aspartate aminotransferase; AUROC: Area under the receiver operating characteristics curve; ELF: Enhanced liver fibrosis; FIB-4: Fibrosis-4; GGT: Gamma-glutamyl transferase; HA: Hyaluronic acid; NAFLD: Non-alcoholic fatty liver disease; PIIINP: Procollagen III N-terminal peptide; TIMP-1: Tissue inhibitor of metalloproteinase-1; PNFI: Pediatric NAFLD fibrosis index